C-TIL052A cell therapy（Fudan University）

N/A

Report date: 2022/12/29 12:33:21

Base Information

Drug NameC-TIL052A cell therapy（Fudan University）

Drug Alias NameC-TIL052A cell therapyAutologous Tumor Infiltrating Lymphocytes (C-TIL052A)C-TIL052A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Tumor Infiltrating Lymphocytes

Mechanisms of ActionCell replacements

TargetsNot applicable

Therapy Area/IndicationsUterine Cervical Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesFudan University

China Registration ClassN/A

Develop Information

Active CompaniesFudan University

Inactive CompaniesN/A

Active IndicationsUterine Cervical Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A